Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 24% ± 7% | |
| epithelial cell | 5 studies | 30% ± 11% | |
| GABAergic neuron | 5 studies | 32% ± 11% | |
| astrocyte | 5 studies | 25% ± 8% | |
| B cell | 4 studies | 21% ± 3% | |
| plasma cell | 4 studies | 28% ± 7% | |
| glutamatergic neuron | 4 studies | 38% ± 10% | |
| neuron | 4 studies | 33% ± 12% | |
| oligodendrocyte | 4 studies | 27% ± 1% | |
| plasmablast | 3 studies | 39% ± 10% | |
| microglial cell | 3 studies | 18% ± 1% | |
| rod bipolar cell | 3 studies | 21% ± 1% | |
| germinal center B cell | 3 studies | 43% ± 20% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 7% | |
| transit amplifying cell | 3 studies | 22% ± 10% | |
| interneuron | 3 studies | 40% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2094.44 | 2642 / 2642 | 100% | 37.05 | 705 / 705 |
| esophagus | 100% | 1280.02 | 1445 / 1445 | 100% | 18.89 | 183 / 183 |
| ovary | 100% | 1780.59 | 180 / 180 | 100% | 12.92 | 430 / 430 |
| uterus | 100% | 1527.68 | 170 / 170 | 100% | 24.26 | 458 / 459 |
| thymus | 100% | 1947.64 | 653 / 653 | 100% | 25.00 | 603 / 605 |
| stomach | 100% | 1074.21 | 359 / 359 | 100% | 14.34 | 285 / 286 |
| breast | 100% | 1253.58 | 459 / 459 | 100% | 19.05 | 1114 / 1118 |
| prostate | 100% | 1371.62 | 245 / 245 | 100% | 19.13 | 500 / 502 |
| lung | 100% | 1153.48 | 576 / 578 | 100% | 22.82 | 1154 / 1155 |
| intestine | 100% | 1506.85 | 966 / 966 | 99% | 15.47 | 524 / 527 |
| bladder | 100% | 1327.00 | 21 / 21 | 99% | 18.74 | 499 / 504 |
| kidney | 100% | 1577.06 | 89 / 89 | 99% | 18.70 | 891 / 901 |
| skin | 100% | 1171.23 | 1809 / 1809 | 98% | 19.08 | 463 / 472 |
| liver | 100% | 1089.65 | 226 / 226 | 98% | 12.07 | 398 / 406 |
| pancreas | 100% | 799.90 | 327 / 328 | 98% | 14.93 | 175 / 178 |
| adrenal gland | 100% | 1527.13 | 258 / 258 | 97% | 19.32 | 224 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 57.45 | 29 / 29 |
| spleen | 100% | 1627.57 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 23.38 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.16 | 1 / 1 |
| adipose | 100% | 1061.58 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1155.11 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 860.72 | 831 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 555.87 | 767 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 14.06 | 76 / 80 |
| peripheral blood | 95% | 1633.30 | 880 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006139 | Biological process | nucleobase-containing compound metabolic process |
| GO_0006015 | Biological process | 5-phosphoribose 1-diphosphate biosynthetic process |
| GO_0006164 | Biological process | purine nucleotide biosynthetic process |
| GO_0060348 | Biological process | bone development |
| GO_0002189 | Cellular component | ribose phosphate diphosphokinase complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004857 | Molecular function | enzyme inhibitor activity |
| GO_0004749 | Molecular function | ribose phosphate diphosphokinase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000287 | Molecular function | magnesium ion binding |
| Gene name | PRPSAP2 |
| Protein name | Phosphoribosyl pyrophosphate synthetase associated protein 2 Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41) Phosphoribosyl pyrophosphate synthase-associated protein 2 |
| Synonyms | |
| Description | FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . FUNCTION: Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. . |
| Accessions | ENST00000441887.5 I3L1T1 C9K0K7 C9JDH0 I3L331 C9JDU5 ENST00000573253.5 ENST00000628609.1 ENST00000575102.5 ENST00000419284.6 ENST00000414602.5 I3L275 I3L3B8 I3L2J4 ENST00000268835.7 [O60256-1] ENST00000422237.5 O60256 E7EW35 ENST00000570450.5 ENST00000395656.6 ENST00000419071.6 [O60256-2] ENST00000460724.1 C9JJS3 ENST00000542013.5 [O60256-3] E7EPA1 ENST00000536323.5 [O60256-4] ENST00000455992.6 ENST00000432893.6 ENST00000574451.5 ENST00000574522.5 I3L164 ENST00000571907.5 ENST00000412418.5 ENST00000492129.5 ENST00000575228.5 I3L4G9 ENST00000487101.5 ENST00000576355.5 ENST00000610773.4 [O60256-4] I3L0S1 |